| |
|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910463222603321 |
|
|
Autore |
Falk John H (John Howard), <1948-, > |
|
|
Titolo |
The museum experience revisited / / John H. Falk and Lynn D. derking |
|
|
|
|
|
Pubbl/distr/stampa |
|
|
London : , : Routledge, , 2016 |
|
|
|
|
|
|
|
ISBN |
|
1-315-41784-7 |
1-315-41785-5 |
1-61132-046-1 |
|
|
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (418 p.) |
|
|
|
|
|
|
Altri autori (Persone) |
|
derkingLynn D <1956-> (Lynn Diane) |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
|
|
Soggetti |
|
Museums - Educational aspects |
Antiquities - Collection and preservation - Social aspects |
Electronic books. |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
First published 2013 by Left Coast Press, Inc. |
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references and index. |
|
|
|
|
|
|
Nota di contenuto |
|
Contents; Foreword; Preface; 1. Introduction: The Contextual Model of Learning; Part I: Before the Visit; 2. The Personal Context: Identity-Related Motivations; 3. The Sociocultural Context: Museums in Society; 4. The Personal Context: Prior Experience, Interest, and Knowledge; Part II: During the Visit; 5. The Physical Context: Exhibitions; 6. The Physical Context: More than Exhibitions; 7. The Sociocultural Context: In the Museum; 8. The Interplay of Contexts: The Museum as Gestalt; Part III. After the Visit; 9. The Museum Experience Remembered; 10. Measuring the Learning Impact of Museums |
Part IV. A Professional's Guide to the Museum Experience11. Supporting the Museum Experience Before, During, and After the Visit; V. Beyond the Visit; 12. The Twenty-First-Century Museum; Appendix; Notes; References; Index; About the Authors |
|
|
|
|
|
|
|
|
Sommario/riassunto |
|
The first book to take a ""visitor's eye view"" of the museum visit when it was first published in 1992, The Museum Experience revolutionized the way museum professionals understand their constituents. Falk and Dierking have updated this essential reference, incorporating advances in research, theory, and practice in the museum field over the last twenty years. Written in clear, non-technical style, The Museum |
|
|
|
|
|
|
|
|
|
|
|
|
|
Experience Revisited paints a thorough picture of why people go to museums, what they do there, how they learn, and what museum practitioners can do to enhance these experiences.</D |
|
|
|
|
|
|
2. |
Record Nr. |
UNINA9910688305203321 |
|
|
Titolo |
Current aspects of radiopharmaceutical chemistry / / edited by Peter Breast |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Basel, Switzerland : , : MDPI - Multidisciplinary Digital Publishing Institute, , [2018] |
|
©2018 |
|
|
|
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (216 pages) : illustrations |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Radioisotopes in pharmacology |
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references. |
|
|
|
|
|
|
Sommario/riassunto |
|
Positron emission tomography (PET) and single-photon emission computed tomography (SPECT) are in vivo molecular imaging techniques which are widely used in nuclear medicine for the diagnosis and treatment follow-up of many major diseases. They use biomolecules as probes, which are labeled with radionuclides of short half-lives, synthesized prior to the imaging studies. These probes are called radiopharmaceuticals. Their design and development require a rather interdisciplinary process involving many different disciplines of natural and health sciences. In addition to their diagnostic and therapeutic purposes in the field of nuclear medicine, radiopharmaceuticals provide powerful tools for in vivo pharmacology during the process of pre-clinical drug development to identify new drug targets, investigate the pathophysiology of diseases, discover potential drug candidates, and evaluate the pharmacokinetics and pharmacodynamics of drugs in vivo. Furthermore, they allow molecular imaging studies in various small-animal models of disease, including |
|
|
|
|
|
|
|
|
|
|
genetically engineered animals. The current collection of articles provides unique examples covering all major aspects in the field. |
|
|
|
|
|
| |